A pulmonary embolism is a blockage in the lungs caused by a blood clot that forms elsewhere in the body and travels through the bloodstream. Symptoms include shortness of breath, chest pain, and anxiety. Diagnosis involves tests like CT scans, ventilation-perfusion scans, and pulmonary angiograms. Treatment focuses on anticoagulant medications like heparin to prevent further clotting and reduce the risk of additional embolisms. Nursing care monitors the patient's oxygenation status and educates them on preventing future clots.
DIAGNOSIS & MANAGEMENT OF PULMONARY HYPERTENSIONKamal Bharathi
Pulmonary hypertension (PH) is defined by a mean pulmonary artery pressure ≥25 mm Hg at rest, measured during right heart catheterization. There is still insufficient evidence to add an exercise criterion to this definition. The term pulmonary arterial hypertension (PAH) describes a subpopulation of patients with PH characterized hemodynamically by the presence of pre-capillary PH including an end-expiratory pulmonary artery wedge pressure (PAWP) ≤15 mm Hg and a pulmonary vascular resistance >3 Wood units. Right heart catheterization remains essential for a diagnosis of PH or PAH. This procedure requires further standardization, including uniformity of the pressure transducer zero level at the midthoracic line, which is at the level of the left atrium. One of the most common problems in the diagnostic workup of patients with PH is the distinction between PAH and PH due to left heart failure with preserved ejection fraction (HFpEF). A normal PAWP does not rule out the presence of HFpEF. Volume or exercise challenge during right heart catheterization may be useful to unmask the presence of left heart disease, but both tools require further evaluation before their use in general practice can be recommended. Early diagnosis of PAH remains difficult, and screening programs in asymptomatic patients are feasible only in high-risk populations, particularly in patients with systemic sclerosis, for whom recent data suggest that a combination of clinical assessment and pulmonary function testing including diffusion capacity for carbon monoxide, biomarkers, and echocardiography has a higher predictive value than echocardiography alone.
Acute respiratory distress syndrome (ARDS) occurs when fluid builds up in the tiny, elastic air sacs (alveoli) in your lungs. The fluid keeps your lungs from filling with enough air, which means less oxygen reaches your bloodstream. This deprives your organs of the oxygen they need to function.
Pulmonary arterial hypertension in congenital heart disease Ramachandra Barik
Pulmonary hypertension (PH) is an increase of blood pressure in the pulmonary artery, pulmonary vein, or pulmonary capillaries, together known as the lung vasculature, leading to shortness of breath, dizziness, fainting, leg swelling and other symptoms. Pulmonary hypertension can be a severe disease with a markedly decreased exercise tolerance and heart failure. It was first identified by Ernst von Romberg in 1891. According to the most recent classification, it can be one of five different types: arterial, venous, hypoxic, thromboembolic or miscellaneous.
Pulmonary embolism (PE) occurs when a blood clot gets lodged in an artery in the lung, blocking blood flow to part of the lung. Blood clots most often start in the legs and travel up through the right side of the heart and into the lungs.
DIAGNOSIS & MANAGEMENT OF PULMONARY HYPERTENSIONKamal Bharathi
Pulmonary hypertension (PH) is defined by a mean pulmonary artery pressure ≥25 mm Hg at rest, measured during right heart catheterization. There is still insufficient evidence to add an exercise criterion to this definition. The term pulmonary arterial hypertension (PAH) describes a subpopulation of patients with PH characterized hemodynamically by the presence of pre-capillary PH including an end-expiratory pulmonary artery wedge pressure (PAWP) ≤15 mm Hg and a pulmonary vascular resistance >3 Wood units. Right heart catheterization remains essential for a diagnosis of PH or PAH. This procedure requires further standardization, including uniformity of the pressure transducer zero level at the midthoracic line, which is at the level of the left atrium. One of the most common problems in the diagnostic workup of patients with PH is the distinction between PAH and PH due to left heart failure with preserved ejection fraction (HFpEF). A normal PAWP does not rule out the presence of HFpEF. Volume or exercise challenge during right heart catheterization may be useful to unmask the presence of left heart disease, but both tools require further evaluation before their use in general practice can be recommended. Early diagnosis of PAH remains difficult, and screening programs in asymptomatic patients are feasible only in high-risk populations, particularly in patients with systemic sclerosis, for whom recent data suggest that a combination of clinical assessment and pulmonary function testing including diffusion capacity for carbon monoxide, biomarkers, and echocardiography has a higher predictive value than echocardiography alone.
Acute respiratory distress syndrome (ARDS) occurs when fluid builds up in the tiny, elastic air sacs (alveoli) in your lungs. The fluid keeps your lungs from filling with enough air, which means less oxygen reaches your bloodstream. This deprives your organs of the oxygen they need to function.
Pulmonary arterial hypertension in congenital heart disease Ramachandra Barik
Pulmonary hypertension (PH) is an increase of blood pressure in the pulmonary artery, pulmonary vein, or pulmonary capillaries, together known as the lung vasculature, leading to shortness of breath, dizziness, fainting, leg swelling and other symptoms. Pulmonary hypertension can be a severe disease with a markedly decreased exercise tolerance and heart failure. It was first identified by Ernst von Romberg in 1891. According to the most recent classification, it can be one of five different types: arterial, venous, hypoxic, thromboembolic or miscellaneous.
Pulmonary embolism (PE) occurs when a blood clot gets lodged in an artery in the lung, blocking blood flow to part of the lung. Blood clots most often start in the legs and travel up through the right side of the heart and into the lungs.
Pulmonary embolism - Diagnosis and managementDr Vivek Baliga
Pulmonary embolism is a common problem seen in medical practice. This presentation by Dr Vivek Baliga discusses the basic aspects and evidence behind current management.
Acute pulmonary embolism - risk stratification and managementPrithvi Puwar
what is the guideline recommendation and ideal to be done in management of acute pulmonary embolism. the presentation includes risk stratification, recommendation and approach to investigations (guidelines based) and management options with evidence.
Deep Venous Thrombosis and Pulmonary Embolism : Diagnostic Approach and Curre...Bassel Ericsoussi, MD
Acute pulmonary embolism: Overview, Diagnosis, Treatment
DVT/PE in pregnancy
Prevalence of PE in COPD exacerbations
Diagnostic vascular ultrasonography
PowerPoint presentation about pulmonary embolism -- Teaching at Zagazig university cardiology department ,
Egypt in 2013 by Islam Ghanem , assistant lecturer of cardiology
SlideShare now has a player specifically designed for infographics. Upload your infographics now and see them take off! Need advice on creating infographics? This presentation includes tips for producing stand-out infographics. Read more about the new SlideShare infographics player here: http://wp.me/p24NNG-2ay
This infographic was designed by Column Five: http://columnfivemedia.com/
No need to wonder how the best on SlideShare do it. The Masters of SlideShare provides storytelling, design, customization and promotion tips from 13 experts of the form. Learn what it takes to master this type of content marketing yourself.
Empowering ACOs: Leveraging Quality Management Tools for MIPS and BeyondHealth Catalyst
Join us as we delve into the crucial realm of quality reporting for MSSP (Medicare Shared Savings Program) Accountable Care Organizations (ACOs).
In this session, we will explore how a robust quality management solution can empower your organization to meet regulatory requirements and improve processes for MIPS reporting and internal quality programs. Learn how our MeasureAble application enables compliance and fosters continuous improvement.
Global launch of the Healthy Ageing and Prevention Index 2nd wave – alongside...ILC- UK
The Healthy Ageing and Prevention Index is an online tool created by ILC that ranks countries on six metrics including, life span, health span, work span, income, environmental performance, and happiness. The Index helps us understand how well countries have adapted to longevity and inform decision makers on what must be done to maximise the economic benefits that comes with living well for longer.
Alongside the 77th World Health Assembly in Geneva on 28 May 2024, we launched the second version of our Index, allowing us to track progress and give new insights into what needs to be done to keep populations healthier for longer.
The speakers included:
Professor Orazio Schillaci, Minister of Health, Italy
Dr Hans Groth, Chairman of the Board, World Demographic & Ageing Forum
Professor Ilona Kickbusch, Founder and Chair, Global Health Centre, Geneva Graduate Institute and co-chair, World Health Summit Council
Dr Natasha Azzopardi Muscat, Director, Country Health Policies and Systems Division, World Health Organisation EURO
Dr Marta Lomazzi, Executive Manager, World Federation of Public Health Associations
Dr Shyam Bishen, Head, Centre for Health and Healthcare and Member of the Executive Committee, World Economic Forum
Dr Karin Tegmark Wisell, Director General, Public Health Agency of Sweden
Medical Technology Tackles New Health Care Demand - Research Report - March 2...pchutichetpong
M Capital Group (“MCG”) predicts that with, against, despite, and even without the global pandemic, the medical technology (MedTech) industry shows signs of continuous healthy growth, driven by smaller, faster, and cheaper devices, growing demand for home-based applications, technological innovation, strategic acquisitions, investments, and SPAC listings. MCG predicts that this should reflects itself in annual growth of over 6%, well beyond 2028.
According to Chris Mouchabhani, Managing Partner at M Capital Group, “Despite all economic scenarios that one may consider, beyond overall economic shocks, medical technology should remain one of the most promising and robust sectors over the short to medium term and well beyond 2028.”
There is a movement towards home-based care for the elderly, next generation scanning and MRI devices, wearable technology, artificial intelligence incorporation, and online connectivity. Experts also see a focus on predictive, preventive, personalized, participatory, and precision medicine, with rising levels of integration of home care and technological innovation.
The average cost of treatment has been rising across the board, creating additional financial burdens to governments, healthcare providers and insurance companies. According to MCG, cost-per-inpatient-stay in the United States alone rose on average annually by over 13% between 2014 to 2021, leading MedTech to focus research efforts on optimized medical equipment at lower price points, whilst emphasizing portability and ease of use. Namely, 46% of the 1,008 medical technology companies in the 2021 MedTech Innovator (“MTI”) database are focusing on prevention, wellness, detection, or diagnosis, signaling a clear push for preventive care to also tackle costs.
In addition, there has also been a lasting impact on consumer and medical demand for home care, supported by the pandemic. Lockdowns, closure of care facilities, and healthcare systems subjected to capacity pressure, accelerated demand away from traditional inpatient care. Now, outpatient care solutions are driving industry production, with nearly 70% of recent diagnostics start-up companies producing products in areas such as ambulatory clinics, at-home care, and self-administered diagnostics.
The dimensions of healthcare quality refer to various attributes or aspects that define the standard of healthcare services. These dimensions are used to evaluate, measure, and improve the quality of care provided to patients. A comprehensive understanding of these dimensions ensures that healthcare systems can address various aspects of patient care effectively and holistically. Dimensions of Healthcare Quality and Performance of care include the following; Appropriateness, Availability, Competence, Continuity, Effectiveness, Efficiency, Efficacy, Prevention, Respect and Care, Safety as well as Timeliness.
Deep Leg Vein Thrombosis (DVT): Meaning, Causes, Symptoms, Treatment, and Mor...The Lifesciences Magazine
Deep Leg Vein Thrombosis occurs when a blood clot forms in one or more of the deep veins in the legs. These clots can impede blood flow, leading to severe complications.
Antibiotic Stewardship by Anushri Srivastava.pptxAnushriSrivastav
Stewardship is the act of taking good care of something.
Antimicrobial stewardship is a coordinated program that promotes the appropriate use of antimicrobials (including antibiotics), improves patient outcomes, reduces microbial resistance, and decreases the spread of infections caused by multidrug-resistant organisms.
WHO launched the Global Antimicrobial Resistance and Use Surveillance System (GLASS) in 2015 to fill knowledge gaps and inform strategies at all levels.
ACCORDING TO apic.org,
Antimicrobial stewardship is a coordinated program that promotes the appropriate use of antimicrobials (including antibiotics), improves patient outcomes, reduces microbial resistance, and decreases the spread of infections caused by multidrug-resistant organisms.
ACCORDING TO pewtrusts.org,
Antibiotic stewardship refers to efforts in doctors’ offices, hospitals, long term care facilities, and other health care settings to ensure that antibiotics are used only when necessary and appropriate
According to WHO,
Antimicrobial stewardship is a systematic approach to educate and support health care professionals to follow evidence-based guidelines for prescribing and administering antimicrobials
In 1996, John McGowan and Dale Gerding first applied the term antimicrobial stewardship, where they suggested a causal association between antimicrobial agent use and resistance. They also focused on the urgency of large-scale controlled trials of antimicrobial-use regulation employing sophisticated epidemiologic methods, molecular typing, and precise resistance mechanism analysis.
Antimicrobial Stewardship(AMS) refers to the optimal selection, dosing, and duration of antimicrobial treatment resulting in the best clinical outcome with minimal side effects to the patients and minimal impact on subsequent resistance.
According to the 2019 report, in the US, more than 2.8 million antibiotic-resistant infections occur each year, and more than 35000 people die. In addition to this, it also mentioned that 223,900 cases of Clostridoides difficile occurred in 2017, of which 12800 people died. The report did not include viruses or parasites
VISION
Being proactive
Supporting optimal animal and human health
Exploring ways to reduce overall use of antimicrobials
Using the drugs that prevent and treat disease by killing microscopic organisms in a responsible way
GOAL
to prevent the generation and spread of antimicrobial resistance (AMR). Doing so will preserve the effectiveness of these drugs in animals and humans for years to come.
being to preserve human and animal health and the effectiveness of antimicrobial medications.
to implement a multidisciplinary approach in assembling a stewardship team to include an infectious disease physician, a clinical pharmacist with infectious diseases training, infection preventionist, and a close collaboration with the staff in the clinical microbiology laboratory
to prevent antimicrobial overuse, misuse and abuse.
to minimize the developme
CHAPTER 1 SEMESTER V PREVENTIVE-PEDIATRICS.pdfSachin Sharma
This content provides an overview of preventive pediatrics. It defines preventive pediatrics as preventing disease and promoting children's physical, mental, and social well-being to achieve positive health. It discusses antenatal, postnatal, and social preventive pediatrics. It also covers various child health programs like immunization, breastfeeding, ICDS, and the roles of organizations like WHO, UNICEF, and nurses in preventive pediatrics.
Defecation
Normal defecation begins with movement in the left colon, moving stool toward the anus. When stool reaches the rectum, the distention causes relaxation of the internal sphincter and an awareness of the need to defecate. At the time of defecation, the external sphincter relaxes, and abdominal muscles contract, increasing intrarectal pressure and forcing the stool out
The Valsalva maneuver exerts pressure to expel faeces through a voluntary contraction of the abdominal muscles while maintaining forced expiration against a closed airway. Patients with cardiovascular disease, glaucoma, increased intracranial pressure, or a new surgical wound are at greater risk for cardiac dysrhythmias and elevated blood pressure with the Valsalva maneuver and need to avoid straining to pass the stool.
Normal defecation is painless, resulting in passage of soft, formed stool
CONSTIPATION
Constipation is a symptom, not a disease. Improper diet, reduced fluid intake, lack of exercise, and certain medications can cause constipation. For example, patients receiving opiates for pain after surgery often require a stool softener or laxative to prevent constipation. The signs of constipation include infrequent bowel movements (less than every 3 days), difficulty passing stools, excessive straining, inability to defecate at will, and hard feaces
IMPACTION
Fecal impaction results from unrelieved constipation. It is a collection of hardened feces wedged in the rectum that a person cannot expel. In cases of severe impaction the mass extends up into the sigmoid colon.
DIARRHEA
Diarrhea is an increase in the number of stools and the passage of liquid, unformed feces. It is associated with disorders affecting digestion, absorption, and secretion in the GI tract. Intestinal contents pass through the small and large intestine too quickly to allow for the usual absorption of fluid and nutrients. Irritation within the colon results in increased mucus secretion. As a result, feces become watery, and the patient is unable to control the urge to defecate. Normally an anal bag is safe and effective in long-term treatment of patients with fecal incontinence at home, in hospice, or in the hospital. Fecal incontinence is expensive and a potentially dangerous condition in terms of contamination and risk of skin ulceration
HEMORRHOIDS
Hemorrhoids are dilated, engorged veins in the lining of the rectum. They are either external or internal.
FLATULENCE
As gas accumulates in the lumen of the intestines, the bowel wall stretches and distends (flatulence). It is a common cause of abdominal fullness, pain, and cramping. Normally intestinal gas escapes through the mouth (belching) or the anus (passing of flatus)
FECAL INCONTINENCE
Fecal incontinence is the inability to control passage of feces and gas from the anus. Incontinence harms a patient’s body image
PREPARATION AND GIVING OF LAXATIVESACCORDING TO POTTER AND PERRY,
An enema is the instillation of a solution into the rectum and sig
Navigating Challenges: Mental Health, Legislation, and the Prison System in B...Guillermo Rivera
This conference will delve into the intricate intersections between mental health, legal frameworks, and the prison system in Bolivia. It aims to provide a comprehensive overview of the current challenges faced by mental health professionals working within the legislative and correctional landscapes. Topics of discussion will include the prevalence and impact of mental health issues among the incarcerated population, the effectiveness of existing mental health policies and legislation, and potential reforms to enhance the mental health support system within prisons.
2. Introduction
The incidence of Pulmonary emboli (PE) in the North
America is 100 persons in 100,000 population. This
means currently one person is experiencing PE in
every 1000 individuals.
Death from PE is usually confirmed after autopsy
results because PE is one of the most misdiagnosed
or under diagnosed diseases.
3. What is pulmonary
embolism?
PE is an obstruction of blood vessels in the lungs,
most often caused by a blood clot. However, PE also
can also be caused by air, fat, or amniotic fluid.
Obstruction of the lung arteries air , fat or amniotic
fluid are rare when compared to blood emboli.
The most common blood clot is formed in the lower
extremities veins and travels to the heart through
the vena cava that occludes the pulmonary arteries
resulting decreased perfusion or dead zone.
5. Pathophysiology of
Pulmonary Embolism
• Under normal conditions:-
There is a balance between activation of clotting
factors and fibrinolysis
• Clotting = fibrinolysis
• Hypercoagulability can be resulted from
+ trauma + malignancy + pregnancy
+ surgery + use oral contraceptive
6. What does Pulmonary
Embolism effect?
The lung’s ventilation is not affected; however, it’s
perfusion is reduced. This is also called mismatched V/Q
(ventilation-perfusion) ratio.
The occluded part of the perfusion is commonly called
dead zone.
PE can be symptomatic or asymptomatic often depending
on the size of the emboli and occluded or non perfused
areas of the lung.
The heart tries to compensate resulting in
= tachycardia
The lungs try to compensate for the shortage of oxygen in
the cells resulting in
= tachypnea
7. Pulmonary Embolism
effect chain
Pulmonary embolism obstructs blood flow to lung
increased pressure on pulmonary artery and reflex
constriction of pulmonary blood vessels poor
pulmonary circulation pulmonary infraction
8. Question 1
Which physiologic effect of a pulmonary embolism
would initially affect oxygenation?
A. A blood clot blocks ventilation; perfusion is
unaffected
B. A blood clot blocks ventilation, producing hypoxia
despite normal perfusion
C.A blood clot blocks perfusion and ventilation,
producing profound hypoxia
D. A blood clot blocks perfusion, producing hypoxia
despite normal or supernormal ventilation
9. ANSWER
Answer D
The clot blocks blood flow to a region of the lung
tissue. That are remains ventilated but because blood
flow is blocked, no gas exchange can occur in that
region and a ventilation-perfusion mismatch is
present. Ventilation isn’t initially affected by a blood
clot because air can still move normally through the
bronchial tree.
10. Question 2
A client with a massive pulmonary embolism is
scheduled to have arterial blood gas analysis
performed. The nurse expects the analysis will
identify:
A. Metabolic acidosis
B. Metabolic alkalosis
C. Respiratory acidosis
D. Respiratory alkalosis
11. ANSWER
Answer D
A client with massive pulmonary embolism will have
a large region or lung tissue unavailable for
perfusion. This causes the client to hyperventilate
and blow off large amounts of carbon dioxide, which
crosses the unaffected alveolar-capillary membrane
more readily than does oxygen and results in
respiratory alkalosis
12. Symptoms of a Pulmonary
Embolism
Symptoms of a pulmonary embolism depend on the
size of the clot and the location in the lungs where it
becomes lodged.
The most common symptom of a pulmonary
embolism is shortness of breath. This may be gradual
or sudden.
13. Other symptoms of a
pulmonary embolism
include:anxiety
clammy or bluish skin
coughing
chest pain that may extend
into your arm, jaw, neck,
and shoulder
fainting
irregular heartbeat
lightheadedness
rapid breathing
rapid heartbeat
restlessness
spitting up blood
weak pulse
15. Question 3
A nurse calls a physician with the concern that a patient has
developed a pulmonary embolism. Which of the following
symptoms has the nurse most likely observed?
A. The patient is somnolent with decreased response to the
family.
B. The patient suddenly complains of chest pain and
shortness of breath.
C. The patient has developed a wet cough and the nurse
hears crackles on auscultation of the lungs.
D. The patient has a fever, chills, and loss of appetite.
16. ANSWER
Answer: B
Typical symptoms of pulmonary embolism include
chest pain, shortness of breath, and severe anxiety.
The physician should be notified immediately. A
patient with pulmonary embolism will not be sleepy
or have a cough with crackles on exam. A patient
with fever, chills and loss of appetite may be
developing pneumonia.
17. Question 4
A male adult client is suspected of having a pulmonary
embolus. A nurse assesses the client, knowing that
which of the following is a common clinical
manifestation of pulmonary embolism?
a. Dyspnea
b. Bradypnea
c. Bradycardia
d. Decreased respirations
18. ANSWER
Answer A.
The common clinical manifestations of pulmonary
embolism are tachypnea, tachycardia, dyspnea, and
chest pain.
19. Question 5
The nurse would identify which of the following clients as
being at the highest risk for developing a pulmonary
embolus?
1. A 19-year-old four days postpartum with an obstetrical
history of placenta previa.
2. An obese 40-year-old man with multiple pelvic fractures
from an auto accident two days ago.
3. A 65-year-old woman who had a fractured hip repaired 10
days ago and who is in physical therapy daily.
4. A 22-year-old leukemic client with a platelet count of
120,000/mm3 and a hemoglobin level of 9.0g.
20. ANSWER
Strategy: Determine how each answer choice relates to
pulmonary embolism.
(1) at high risk for shock and bleeding complications
(2) correct–obesity, immobility, and pooling of blood in
the pelvic cavity contribute to development of pulmonary
emboli
(3) client does not have a high risk for pulmonary emboli
(4) at high risk for shock and bleeding complications
22. Assessment
Pulmonary Embolism is very difficult to diagnose due to its
nonspecific signs and symptoms. Pulmonary embolism should be
suspected with patients with new worsening dyspnea or
sustained hypotension without other explanation. However, it is
also common that a DVT or embolus produces no significant
symptoms and may be an incidental finding when the patient
undergoes imaging for other reasons (Morton & Fontaine, 2013,
p.563).
Because pulmonary embolism almost always occurs in
conjunction with deep vein thrombosis, some doctors refer to the
two conditions together as venous thromboembolism (VTE).
23. Assessment (subjective)
Chest Pain: sub sternal, localized; type- crushing,
sharp, stabbing with respirations
Sudden onset of profound dyspnea.
Restless, irritable, anxious
Sense of impending doom
24. Assessment (Objective)
Respirations: either rapid,
shallow or deep gasping.
Elevated temperature.
Auscultation: friction rub,
crackles; diminished breath
sounds
Cough; hemoptysis
ECG changes that reflect
right sided heart failure
Echocardiogram shows
increased pulmonary
dynamics
Shock
Tachycardia
Hypotension
Skin, cold, clammy
25. Assessment findings
Apprehension and
restlessness
Blood-tinged sputum
Chest pain
Cough
Crackles and wheezes on
auscultation
Cyanosis
Distended neck veins
Dyspnea
Feeling of impending doom
Hypotension
Petechiae over the chest and
axilla
Shallow respirations
Tachypnea and tachycardia
26. Question 6
A client with a pulmonary embolism tells the nurse
that he feels a sense of “impending doom.” The
nurse recognizes that this manifestation is caused by
what?
A. Inflammatory reaction in the lung parenchyma
B Loss of chest expansion
C. Loss of lung tissue
D. Sudden reduction in adequate oxygenation
27. ANSWER
Answer D
The client with a pulmonary embolism has a portion
of the lung not involved in oxygenation, causing the
client to feel apprehensive. If the area involved is
large, the apprehension can be great, giving the
client the feeling of “impending doom.”
28. How Is a Pulmonary
Embolism Diagnosed?
Diagnosing pulmonary embolism can be difficult, because there
are many other medical conditions, such as a heart attack or an
anxiety attack, that can cause similar symptoms.
To diagnosis PE, diagnosis depends on an accurate and thorough
medical history and ruling out other conditions. The doctor will
need to know about the patient’s symptoms and risk factors for
pulmonary embolism. This information, combined with a careful
physical exam, will point to the initial tests that are best suited
to diagnose a deep vein thrombosis or pulmonary embolism.
29. Diagnosis Tests
pulmonary angiography: this test involves making a small
incision so the doctor can guide specialized tools through
the veins. A special dye is injected so that the vessels of
the lung can be seen. This is the determining test for the
diagnosis of Pulmonary Embolism.
duplex venous ultrasound: this test uses radio waves to
visualize the flow of blood and to check for blood clots in
the legs.
venography: this is a specialized X-ray of the veins of the
legs.
30. One or more of the following
tests is done in order to
diagnose PE
chest X-ray: this standard, noninvasive test allows doctors to see the heart
and lungs in detail, as well as any problems with the bones around the
lungs.
electrocardiography (ECG): this test measures the heart’s electrical activity.
magnetic resonance imaging (MRI): this scan uses radio waves and
magnetic field to produce detailed images.
computed tomography (CT) scan: this scan gives the doctor the ability to
see cross-sectional images of the lungs.
31. Question 7
A client is suspected of having a pulmonary embolism
and asks the nurse how the doctor will definitively
determine the diagnosis. The nurse anticipates that
the physician will order.
A. Arterial blood gas (ABG) analysis
B. Chest X-Ray
C. Pulmonary Angiogram
D. Ventilation-perfusion scan
32. ANSWER
Answer C
A pulmonary angiogram is used to definitively
diagnose a pulmonary embolism. A catheter is passed
through the circulation to the region of the
occlusion; the region can be outlined with an
injection of contrast medium and viewed by
fluoroscopy. This shows the location of the clot as
well as the extent of the perfusion defect.
33. Overview of Management
Treat with medicines, procedures, and other
treatments
The main goals of treatment
Stop the blood clot from getting bigger
Prevent new clots from forming
34. Medications
Anticoagulants are prescribed when pulmonary
embolism is diagnosed or suspected
Heparin
Warfarin
Rivaroxaban
Fondaparinux
Most commonly the patient will take an anticoagulant
for at least 3 months after pulmonary embolism to
reduce the risk of having another blood clot.
35. Medications cont..
Thrombolytics or clot- dissolving medicines are not
commonly used to treat pulmonary embolism unless
in a life threatening situation.
These drugs can greatly increase the risk of serious
bleeding.
Reteplase (Retavase)
Alteplase (Activase, Cathoflo Activase)
36. Embolectomy
The removal of a clot
May be surgical or may be done with a minimal
invasive procedure that uses a catheter.
This treatment is used only in rare cases.
37. Other types of treatment
If medicines don’t work your doctor may suggest a
vena cava filter.
This keeps blood clots from traveling to your lungs.
Used when anticoagulants are not an option, when
clots form despite anticoagulant use, or when there is
an increased risk of death or severely restricted
lifestyle if another pulmonary embolism occurs.
38. Question 8
A definitive diagnosis of pulmonary embolism has
been made for a client. The nurse anticipates which
medication will be ordered?
A. Warfarin (Coumadin)
B. Heparin
C. Streptokinase (Streptase)
Acyclovir (Zovirax)
39. ANSWER
Answer B
Heparin is started I.V. once a pulmonary embolism is
diagnosed to reduce further clot formation. When a
therapeutic level of heparin is established, warfarin is
started. It can take up to 3 days before a therapeutic
level of warfarin is achieved.
40. Question 9
The nurse is teaching a client diagnosed with a
pulmonary embolism about the prescribed heparin
therapy. The nurse determines that teaching has
been effective when the client states that heparin is
given to:
A. Dissolve the clot
B. Break up the pulmonary embolism
C. Slow the development of other clots
D. Prevent clots from breaking off and embolizing to
the lung
42. Priority Nursing Actions
1. Notify the Rapid Response
Team
2. Reassure the client and
elevate the head of the
bed
3. Prepare to administer
oxygen
4. Obtain vital signs and
check lung sounds
5. Prepare to obtain an arterial
blood gas.
6. Prepare for the
administration of heparin
therapy or other therapies.
7. Document the event,
interventions taken, and the
client’s response to treatment.
43. Nursing care goals
Monitor for signs of respiratory distress
Health teaching
Prevent from further occurrence
Need to continue medication
Follow-up care
44. Question 10
Nursing management of a client with a pulmonary
embolism will primarily focus on which action?
A. Assessing oxygenation status
B. Monitoring the oxygen delivery device
C. Monitoring for other sources of clots
D. Determining whether the client requires another
ventilation-perfusion scan
45. ANSWER
Answer A
Nursing management of a client with a pulmonary
embolism focuses on assessing oxygenation status
and ensuring that treatment is adequate. If the
client’s status begins to deteriorate, it’s the nurse’s
responsibility to contact the physician and attempt to
improve oxygenation.
46. How Can Pulmonary
Embolism Be Prevented?
Preventing pulmonary embolism (PE) begins with preventing deep
vein thrombosis (DVT). Knowing whether you're at risk for DVT and
taking steps to lower your risk are important.
Daily use of anticoagulant medicines may help prevent recurring
pulmonary embolism by stopping new blood clots from forming and
stopping existing clots from growing.
If you've already had DVT or PE, you can take more steps to prevent
new blood clots from forming. Visit your doctor for regular checkups.
Also, use compression stockings to prevent chronic (ongoing)
swelling in your legs from DVT (as your doctor advises).
47. Important steps to lower
your risk of PE
Exercise your lower leg muscles if you're sitting for a
long time while traveling.
Get out of bed and move around as soon as you're
able after having surgery or being ill. The sooner you
move around, the better your chance is of avoiding a
blood clot.
Take medicines to prevent clots after some types of
surgery (as your doctor prescribes).
Follow up with your doctor.
48. References
Pulmonary Embolism-Medications. (2013, February 5). Retrieved
September 15, 2014, from
http://www.webmd.com/lung/tc/pulmonary-embolism
Lisko, S. (2014). Respiratory Disorders. In NCLEX-RN questions &
answers made incredibly easy (Sixth ed., pp. 112-114).
Philadelphia, PA: Lippincott Williams & Wilkins.
Morton, P. (2013). Common Respiratory Disorders. In Critical
care nursing: A holistic approach (10th ed., pp. 561-565).
Philadelphia, PA: Lippincott Williams & Wilkins.
Silvestri, L. (2011). Respiratory System. In Saunders
comprehensive review for the NCLEX-RN examination (5th ed., p.
743). St. Louis, Mo.: Elsevier/Saunders.